Security key
45254E107
Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX)
CUSIP: 45254E107
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Class A common stock, par value $0.001 per share
- Shares outstanding
- 66,027,379
- Total 13F shares
- 12,063,607
- Share change
- -541,150
- Total reported value
- $172,475,348
- Price per share
- $14.32
- Number of holders
- 30
- Value change
- -$5,229,083
- Number of buys
- 14
- Number of sells
- 18
Report period
Q3 2022
Institutions
30
Top holders
10
IMRX full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Immuneering Corp SEC filings
Immuneering Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45254E107
Recent filing periods:
Top shareholders of IMRX - Immuneering Corp - Class A common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.3%
|
4,142,829
|
$22,413,000 | — | 30 Jun 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.5%
|
2,286,181
|
$12,368,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.3%
|
2,199,209
|
$11,898,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.1%
|
1,356,670
|
$7,339,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
740,623
|
$4,007,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
0.34%
|
223,151
|
$1,207,000 | — | 30 Jun 2022 | |
| BUCKINGHAM STRATEGIC WEALTH, LLC |
13F
|
Company |
0.3%
|
200,200
|
$1,083,000 | — | 30 Jun 2022 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
200,000
|
$1,082,000 | — | 30 Jun 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.22%
|
147,661
|
$799,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
128,653
|
$696,000 | — | 30 Jun 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.13%
|
85,000
|
$460,000 | — | 30 Jun 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.13%
|
82,536
|
$429,270 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
74,600
|
$403,000 | — | 30 Jun 2022 | |
| Kore Private Wealth LLC |
13F
|
Company |
0.09%
|
59,024
|
$319,000 | — | 30 Jun 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
34,949
|
$189,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
25,537
|
$138,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
25,035
|
$135,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
18,584
|
$101,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
18,287
|
$98,000 | — | 30 Jun 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
17,138
|
$93,000 | — | 30 Jun 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.03%
|
16,893
|
$91,000 | — | 30 Jun 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
15,942
|
$86,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
15,683
|
$85,000 | — | 30 Jun 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
11,100
|
$60,000 | — | 30 Jun 2022 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.02%
|
10,498
|
$57,000 | — | 30 Jun 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
4,160
|
$22,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,808
|
$15,000 | — | 30 Jun 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,591
|
$9,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,401
|
$8,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,133
|
$6,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
929
|
$6,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
816
|
$4,000 | — | 30 Jun 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
165
|
$1,000 | — | 30 Jun 2022 | |
| Biren Amin |
3/4/5
|
CFO, TREASURER |
—
class O/S missing
|
7,898
|
$23,773 | — | 12 May 2022 |
Institutional Holders of Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) as of Q3 2022
As of 30 Sep 2022,
Immuneering Corp - Class A common stock, par value $0.001 per share (IMRX) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,063,607 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, CITADEL ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., FMR LLC, BUCKINGHAM STRATEGIC WEALTH, LLC, GEODE CAPITAL MANAGEMENT, LLC, and TD ASSET MANAGEMENT INC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
33
Q3 2022 holders
30
Holder diff
-3
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.